The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118668584 11866858 4 F 20140925 20160614 20151224 20160706 EXP PHJP2015JP021972 NOVARTIS 37.80 YR M Y 66.00000 KG 20160706 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118668584 11866858 1 PS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 2 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 3 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 4 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 5 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 6 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 7 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 8 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 9 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 10 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 11 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 12 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 13 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 14 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 15 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 16 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 17 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 18 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 40 MG Y U 22334 5 MG TABLET QD
118668584 11866858 19 C SANDOSTATIN OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO 21.9459991 MG Y 0 30 MG INJECTION /month
118668584 11866858 20 C URSODEOXYCHOLIC ACID URSODIOL 1 Oral 600 MG, UNK 0 600 MG
118668584 11866858 21 C SILECE FLUNITRAZEPAM 1 Oral 1 MG, UNK 0 1 MG
118668584 11866858 22 C LIPACREON PANCRELIPASE 1 Oral 1800 MG, UNK 0 1800 MG
118668584 11866858 23 C BIOFERMIN BACILLUS SUBTILISLACTOBACILLUS ACIDOPHILUSSTREPTOCOCCUS FAECAIS 1 Oral 1 G, UNK 0 1 G
118668584 11866858 24 C PARIET RABEPRAZOLE SODIUM 1 Oral 10 MG, UNK 0 10 MG
118668584 11866858 25 C WARFARIN WARFARIN 1 Oral 3 MG, UNK 0 3 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118668584 11866858 1 Pancreatic neuroendocrine tumour
118668584 11866858 19 Pancreatic neuroendocrine tumour
118668584 11866858 20 Cholestasis
118668584 11866858 21 Insomnia
118668584 11866858 22 Pancreatic insufficiency
118668584 11866858 23 Gastroenteritis
118668584 11866858 24 Gastrooesophageal reflux disease
118668584 11866858 25 Portal vein thrombosis

Outcome of event

Event ID CASEID OUTC COD
118668584 11866858 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118668584 11866858 Blood creatine phosphokinase increased
118668584 11866858 Malaise
118668584 11866858 Malignant neoplasm progression
118668584 11866858 Myalgia
118668584 11866858 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118668584 11866858 1 20140918 20140925 0
118668584 11866858 2 20141009 20141016 0
118668584 11866858 3 20141023 20141106 0
118668584 11866858 4 20141120 20141127 0
118668584 11866858 5 20141211 20141221 0
118668584 11866858 6 20150108 20150115 0
118668584 11866858 7 20150129 20150205 0
118668584 11866858 8 20150305 20150312 0
118668584 11866858 9 20150326 20150402 0
118668584 11866858 10 20150416 20150423 0
118668584 11866858 11 20150507 20150514 0
118668584 11866858 12 20150528 20150604 0
118668584 11866858 13 20150618 20150625 0
118668584 11866858 14 20150715 20150722 0
118668584 11866858 15 20150806 20150813 0
118668584 11866858 16 20150827 20150903 0
118668584 11866858 17 20151015 20151022 0
118668584 11866858 18 20151112 20151210 0
118668584 11866858 19 20140904 20151029 0

Execution Time: 0.015694141387939 seconds (ucode:5231321). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.